Skip to content Skip to footer

International Cannabis Weekly: 255

July 8, 2022

Highlights

Share this story

UK FOOD STANDARDS AGENCY PUBLISHES FINAL LIST OF ALMOST 12,000 CBD PRODUCTS PERMITTED FOR SALE

In March, the UK’s Food Standard Agency (FSA) published a list of CBD products permitted for sale, containing some 3,500 companies. That number has since increased to 12,000 through further requests to have products put on the public list – a ‘milestone’ for the CBD industry in England and Wales.

Steve Moore, founder of the Association for the Cannabinoid Industry (ACI), said that the most recent developments are ‘an indication that the UK is moving faster than the EU and US at advancing safety regulation.’

READ MORE »

US ARMY LOOKS TO HEMP FABRIC FOR NEW SNIPER UNIFORMS

READ MORE »

ALBANIAN PRIME MINISTER TO ALLOW CANNABIS CULTIVATION FOR EXPORT

READ MORE »

Highlights

Share this story
Europe

Highlights

Share this story
Exclusive

EXCLUSIVE: EUROPEAN CANNABIS INDUSTRY UPDATE

Conor O’Brien, Lead Analyst at Prohibition Partners and author of The European Cannabis Report: 7th Edition, took to the stage at Cannabis Europa last week to review some of the report’s key findings, and to provide an industry update since the report’s publication earlier this year.

The key message to delegates at Cannabis Europa was to recognise the ‘size of the opportunity to help millions of patients around the continent, and the immediacy of this opportunity’.

READ MORE »

Highlights

Share this story
United States
  • Texan university receives US$3.7 million grant from US Department of Energy to 3D print buildings using hempcrete.
  • Minnesota legalises low-dose cannabis edibles containing delta-9 THC, though the compound remains illegal in the state.
  • A Kentucky medical cannabis advisory committee of experts is formed to advise governor on medical cannabis access.
  • North Carolina legalises hemp as agricultural crop, after industry was operating under legal exception since 2017.
  • A Pennsylvanian bill protecting banks and insurers working with medical cannabis businesses to be signed by governor.
  • BioHarvest Sciences announces 99% growth in Q2 of 2022 when compared to the same quarter 2021.
  • Congressional lawmakers file amendments to the NDAA to improve medical cannabis access for veterans.

Highlights

Share this story
Canada

Highlights

Share this story
Upcoming Event

The International Cannabis Business Conference is coming back to Germany on July 19-20th. Offering world-class networking opportunities, the Berlin International Cannabis Business Conference is the largest B2B cannabis trade event in Europe and the longest-running cannabis B2B conference on the continent. Representatives from 85 countries are expected to attend, and the event will feature over 300 exhibitors and sponsors.

The conference will feature a unique blend of cannabis policy, advocacy, industry, and networking. In addition to the Berlin B2B event, the International Cannabis Business Conference will also offer a one-day Global Investment Forum on July 18th.

REGISTER NOW »

Highlights

Share this story
LATAM & The Caribbean
  • A Brazilian bill to regulate the cultivation of cannabis for medical and scientific purposes is presented to parliament.
  • The Brazilian Parliamentary Front invites specialists to public hearing discussing the potential of the industrial hemp industry.
  • Brazilian Association for Medical Cannabis and university to research cannabis production and extraction methods.
  • Argentina legalises the sale of cannabis seeds for cultivation for research and medicinal purposes.

Highlights

Share this story
APAC

Highlights

Share this story
Africa & The Middle East
Latest Issues

Insights

on the global cannabis industry

International Cannabis Weekly newsletter brings you the most important developments, news and informed commentary on the global cannabis industry. Join our community of 80,000+ subscribers.

Market Briefing Request

Please complete your details and a representative will be in contact

In Depth Analysis Session Request

Please complete your details and a representative will be in contact

Data Access Request

Please complete your details and a representative will be in contact